GSE240109 sorafenib 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE240109_sorafenib_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE240109_sorafenib_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE240109_sorafenib_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE240109_sorafenib_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

uncharacterized LOC128125822

Gene

long intergenic non-protein coding RNA 2709

Gene

long intergenic non-protein coding RNA 2747

Gene

uncharacterized LOC124900414

Gene

TMEM132D antisense RNA 1

Gene

uncharacterized LOC100128770

Gene

JAKMIP2 antisense RNA 1

Gene

RBBP4 pseudogene 2

Gene

taste 2 receptor member 6, pseudogene

Gene

TBC1 domain family member 3 pseudogene 5

  • Gene

    uncharacterized LOC128125822


  • Gene

    long intergenic non-protein coding RNA 2709


  • Gene

    long intergenic non-protein coding RNA 2747


  • Gene

    uncharacterized LOC124900414


  • Gene

    TMEM132D antisense RNA 1


  • Gene

    uncharacterized LOC100128770


  • Gene

    JAKMIP2 antisense RNA 1


  • Gene

    RBBP4 pseudogene 2


  • Gene

    taste 2 receptor member 6, pseudogene


  • Gene

    TBC1 domain family member 3 pseudogene 5

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.